Do you find our website to be helpful?
Yes   No




1. Evaluation of Pain in Trigeminal Neuralgia Patients Following Gamma Knife Radiosurgery Treatment. Principal Investigator.

2. Intralesional Adoptive Cellular Therapy of Glioblastomas w/ Interleukin-2 Stimulated Autologous Lymphocytes. Co-Principal Investigator

3. Outcomes for Glioma Patients Undergoing Intracranial Treatment with Lymphokine Activated Killer Cells (LAK): Outcomes and Comparisons to Matched Controls. Co-Principal Investigator

4. Deep Brain Stimulation of the Subthalamic Nucleus for the Treatment of Parkinson’s Disease. Co-Principal Investigator, closed April 2002.

5. A Retrospective Review of Gynecologic Patients with Metastatic Disease to the Brain Treated with Gamma-Knife Surgery. Co-Principal Investigator, closed August 2005.

6. NTI 0302: A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated with Peritumoral Brain Edema in Patients with Primary Malignant Glioma. Principal Investigator, December 2006.

7. NTI 0303: A Phase III Randomized, Double-Blinded, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) To Placebo For Control Of Symptoms Associated With Peritumoral Brain Edema In Patients With Malignant Brain Tumor Who Require Chronic Administration Of High-Dose Dexamethasone. Principal Investigator, December 2006.

8. NTI 0501: An Open-Label Extended Use Study of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in the Dexamethasone-Sparing Trials NTI 0302 or NTI 0303. Principal Investigator, December 2006.

9. UCB Pharmaceuticals: A Retrospective Review of Tolerability and Efficacy of Anti-Epileptic Drugs in Patients Who Underwent Gamma Knife for Brain Tumor. Sub-Investigator, December 2006.

Christopher Duma, MD, FACS
3900 West Coast Highway, Suite 300
Newport Beach, CA 92663
Phone: 949-209-9232
Fax: 949.642.4833
Office Hours

Get in touch